The Link to Immunodeficiency: Targeted Treatment
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 6
1.00 CME/CE

Learning Objectives:
  1. Describe impaired tolerance mechanisms among patients with autoimmunity and primary immunodeficiency
  2. Discuss current approach to treat autoimmune cytopenias, the most common autoimmune complications among patients with autoimmunity and primary immunodeficiencies
  3. Discuss targeted and innovative therapies for autoimmunity in certain immunodeficiencies
Discussion Leader
Jolan E. Walter, MD PhD
Discussion Leader
Troy R. Torgerson, MD PhD
See more of: Session